Safety & Efficacy of Extended Longevity Protocol

Inclusion Criteria: * 8 Men and 7 Women * Must between 55-75 years old * Patient must be able to comply with treatment plan and laboratory tests * Patients must have adequate immune system function, with no known immunodeficiency disease Exclusion Criteria: * Neoplastic cancer within 5 years prior to screening, except for cutaneous basal cell or squamous cell cancer resolved by excision * No immune system issues or immunodeficiency disease * No history of viral illness which could be reactivated by immune downregulation * Presence of clinically significant acute or unstable cardiovascular and cerebrovascular (stroke) disease * Diagnosis of a transient ischemic attack in the 6 months prior to screening * Patients infected with hepatitis, C or HIV * Patients with Body Mass Index (BMI) \> 40 kg/m2 * Presence of active infection * Any other illness, psychiatric disorder, alcohol or chemical dependence that in the opinion of the investigator would render a patient unsuitable to participate in the study * Unable or unwilling to provide required blood sample for testing